The Re-Emergence of COVID-19 in 2022 Has Affected People’s Views on Vaccines

Author:

Wu Yufei,Li HuanjieORCID,Wang Yunshan

Abstract

The recurrence of the COVID-19 pandemic in 2022 has had a great impact on people’s mentality, although the government has controlled it through a series of effective measures. What is noteworthy is that the public opinion on vaccines has changed significantly, and at present, the level of public’s trust in the COVID-19 vaccine is what we are concentrating on. For the current situation, new measures should be explored. Vaccines have been proven to be effective in reducing the rate of serious cases and death among infected people. However, vaccination rates still need to be improved, especially among the elderly. For people with low antibody levels, the fourth injection is recommended. Studying vaccines effective against virus mutation is the focus of future research.

Funder

National Natural Science Foundation of China

The Second Science and Technology Development Plan of Jinan Municipal Health Commission

Jinan Clinical Medical Science and Technology Innovation Fund

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference20 articles.

1. Coronavirus Disease 2019 (COVID-19): A Perspective from China;Radiology,2020

2. First Case of 2019 Novel Coronavirus in the United States;N. Engl. J. Med.,2020

3. Transmission Routes Analysis of SARS-CoV-2: A Systematic Review and Case Report;Front. Cell Dev. Biol.,2020

4. The association between lifestyle and COVID-19 vaccine hesitancy in China: A large-scale cross-sectional survey;J. Affect. Disord.,2022

5. Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost;Emerg. Microbes Infect.,2022

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3